enGene Therapeutics (ENGN) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD82,968.20+0.49%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

enGene Therapeutics Inc (ENGN) Stock Price, Quote, News & History

ENGNNASDAQ

Trade with Public

Trade with Public

$1.73

-0.05-2.81%

Last update: Oct 9, 3:59 PM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.76

Close

$1.73

Volume / Avg.

351.51K / 769.48K

Day Range

$1.73 - $1.73

52 Wk Range

1.40 - 12.25

Market Cap

$119.29M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

38

Short Interest

2.56%

Days to Cover

1.81

Recent enGene Therapeutics Inc. News

This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Wall Street analysts updated ratings for CURB, INTU, ENGN. See their outlooks and targets at Benzinga's analyst ratings page.

Avi Kapoor

W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday

Top analysts changed ratings on top names, including Sunrun, enGene Therapeutics, Camp4 Therapeutics, PennyMac Financial, Dave & Buster's, Neumora Therapeutics, Extra Space Storage, & W. P. Carey. See full list here.

Avi Kapoor

Why Is enGene Therapeutics Stock Falling Friday?

enGene stock sinks after Phase 2 bladder cancer trial shows durability concerns. Analysts slash price forecasts as the sell-off intensifies.

Kaustubh Bagalkote

Dow Dips 350 Points; US Foods Posts Downbeat Earnings

Dow falls over 100 points, S&P 500 and NASDAQ also down. Tech sector up, energy stocks down. US Foods reports lower Q1 earnings and sales. Agilon Health, Aaon, and Rackspace Technology see gains while Entrada, Fastly, and enGene Therapeutics decline. Euro zone and Asian markets mixed.

Avi Kapoor

US Stocks Mixed; Dow Falls Over 100 Points

US stocks higher Thursday morning, Dow down 0.28%, Nasdaq up 0.50%, S&P 500 up 0.07%. Tech sector up 1.1%, energy sector down 2.8%. McDonald's reports strong earnings and sales.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-103.31M

Investing Cash Flow (TTM)

-32.04M

Financing Cash Flow (TTM)

143.75M

Free Cash Flow (TTM)

-104.00M

Capital Expenditure (TTM)

-688.00K

Net Change in Cash (TTM)

8.40M

Analyst Trends and Forecast

1

Apr

1

5

May

1

1

Jun

1

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$117.11M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.52

Earnings Yield % (TTM)

-115.64%

Earnings Yield % (FWD)

-110.61%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.44

Company Debt

Total Debt

$25.35M

LT Debt

$25.16M

LT Debt Issuance (TTM)

$25.00M

LT Debt Repayment (TTM)

-$23.05M

Total Cash

$41.03M

Debt to Equity

0.14

Issuance of Debt (TTM)

$1.95M

Repayment of Debt (TTM)

-$23.05M